Biological
Proposed congressional legislation would overhaul the Strategic National Stockpile (SNS), expand domestic manufacturing of medical supplies and improve America’s preparedness for public health emergencies.
U.S. Sens. Bill Cassidy (R-LA) and Maggie Hassan (D-NH) on June 8 unveiled the... Read More »
The Senate unanimously advanced Monday legislation designed to support American public servants who have incurred brain injuries from likely directed energy attacks.
Intelligence Committee Chairman Sen. Mark R. Warner (D-VA) joined Sens. Susan Collins (R-ME), Intelligence Committee Vice... Read More »
According to new research from National Institutes of Health (NIH) scientists at the Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the oral antiviral drug TEMPOL could limit SARS-CoV-2 infection capabilities.
Though still considered experimental, the drug’s... Read More »
Basel, Switzerland-based pharmaceutical company BioVersys has secured a $4.35 million funding allotment from CARB-X to develop new antibiotics to treat life-threatening infections caused by ESKAPE pathogens.
The pathogens are identified as bacteria that have developed resistance to most current,... Read More »
President Joe Biden’s first budget proposal would authorize the largest funding increase in nearly two decades for the Centers for Disease Control and Prevention (CDC), going above and beyond funding the agency’s disease-focused work at the U.S. Department of Health and Human Services... Read More »
The nonprofit Nuclear Threat Initiative (NTI) | bio virtually convened an interdisciplinary group of experts and world leaders earlier this month to push for a global organization to reduce biotechnology risks, promote biosecurity and strengthen international oversight of life sciences... Read More »
Academia and the private sector must be in a collaborative relationship with the United States government to invest in the research and development of technologies that will prevent a future pandemic, experts said on Wednesday during a webinar hosted by the Capitol Hill Steering Committee on... Read More »
A phase two clinical study of the Emergent BioSolutions, Inc. chikungunya virus vaccine candidate has been shown to spur antibodies, reflecting a persistent immune response for two years, after just a single dose.
There is currently no vaccine to prevent or treat chikungunya virus infection,... Read More »
As part of a new Memorandum of Understanding between the World Health Organization (WHO) and the Swiss Confederation, the first facility in the WHO BioHub System was agreed to this week.
Such facilities, first announced in November 2020, will serve as centers for reception, sequencing, storage,... Read More »
The U.S. Government Accountability Office (GAO) on Friday issued risk mitigation steps that the U.S. Department of Homeland Security (DHS) should consider during its acquisition of a new system to replace BioWatch, the federal government’s current biodetection system for detecting aerosolized... Read More »
Up to $4.1 million in non-dilutive funding from nonprofit CARB-X was announced this week for Summit Therapeutics to help develop a first-in-class antibiotic to treat multidrug-resistant infections, and specifically, carbapenem-resistant Enterobacteriaceae (CRE) infections.
This funding will aid... Read More »
America’s historically underfunded public health system played a major role in the nation’s laggard COVID-19 response, according to a new report released by the Trust for America’s Health (TFAH).
And while it’s too soon to calculate with precision, it is likely that the United States... Read More »
In a call backed by the Infectious Diseases Society of America (IDSA), a bipartisan collection of more than 60 United States representatives wrote to House appropriators last week, asking for increased federal resources to address the growing threat of antimicrobial resistant (AMR)... Read More »
When Ebola was a low priority for the private sector, the Department of Defense (DOD) was one of the few organizations that funded early-stage research and development on vaccines and treatments. The division of the DoD that played a critical role in that research was the Chemical and Biological... Read More »
Los Alamos National Laboratory (LANL) researchers are espousing the benefits of a device capable of detecting biothreats from samples such as blood, water, CSF, food, and animal samples.
The Portable EnGineered Analytic Sensor with aUtomated Sampling (PEGASUS) is a miniaturized waveguide-based... Read More »
The Defense Advanced Research Projects Agency (DARPA) recently awarded contracts to FLIR Systems, Leidos, and Charles River Analytics to create lightweight materials and more adaptable countermeasures for equipment protective against chemical and biological threats.
The problem is, while... Read More »
A new report by the World Health Organization (WHO) shows that there remains a relative dearth of antibacterial treatments in the pipeline, despite the growing threat of antibiotic resistance.
The WHOʻs annual Antibacterial Pipeline Report found that of the 43 antibiotics that are currently in... Read More »
To provide real-time updates on federal actions that could help defend against biological threats, the Bipartisan Commission on Biodefense has created an interactive recommendations tracker of completed, in-progress, and items of inaction.
“This new and interactive tracker will build on the... Read More »
A panel of public health experts and U.S. senators agreed on several steps Congress should take to prevent or remediate the next pandemic, basing their proposals on lessons learned during the 14 months working to resolve the COVID-19 health crisis.
Among their recommendations, aired during a... Read More »
FLIR Systems, Inc. announced Monday that it had won a contract with the Defense Advanced Research Projects Agency (DARPA) to develop new fabrics embedded with catalysts and chemical agents that can fight and reduce chemical and biological threats on contact.
The fabrics will be incorporated... Read More »
The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) has earmarked funds to develop capabilities to monitor the current COVID-19 pandemic and other future biological events.
The agency has awarded $199,648 to Chapel Hill, North Carolina-based Mesur.io Inc. for... Read More »
According to a new study from the Galveston National Laboratory, published last week in Nature Communications, combining monoclonal antibodies and the antiviral remdesivir can make for a potent defense against the lethal Marburg virus (MARV).
Conducted at the University of Texas Medical Branch... Read More »
Cipla Therapeutics, and SIGA Technologies, Inc, announced Tuesday that they would be entering into a strategic partnership to deliver innovation and access to novel antibacterial drugs, particularly to fight biothreats.
According to the World Health Organization (WHO), anti-microbial resistance... Read More »
A Stewardship and Access Plan Development Guide for countering the spread of antibiotic-resistant superbugs was developed and released this week by CARB-X, some of its leading funders and major antibacterial researchers.
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator... Read More »
Nuclear Threat Initiative (NTI) and Munich Security Conference (MSC) personnel recently collaborated to convene 19 current and former global leaders and experts to address reducing high-consequence biological threats.
The endeavor was offered in conjunction with the MSC’s “Beyond... Read More »
Warning that antibiotic resistance is one of the greatest public health threats of the age, the Infectious Diseases Society of America (IDSA) and several partner organizations wrote to House leaders last week urging them to create a comprehensive One Health approach to counter the rising... Read More »
The BioWatch Program, established by Congress in 2003, transferred to the U.S. Department of Homeland Security’s Countering Weapons of Mass Destruction (CWMD) office in 2018 with a whopping budget averaging $76 million per fiscal year from 2018 to 2020.
According to BioWatch officials, the... Read More »
According to a new report from the U.S. Centers for Disease Control and Prevention (CDC) and the University of Utah, the costs of antibiotic resistance among diseases are growing, leading to billions of dollars in health care costs and increasing rates of infections.
According to “National... Read More »
Nuclear Threat Initiative (NTI) officials indicated its recent Global Biosecurity Dialogue resulted in participants pledging to take 12 specific actions to advance global biosecurity along with eight jointly developed priority areas.
More than 170 government officials, health and biosecurity... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Luminex Corporation announced a collaboration on advanced development support of a single test to rapidly detect and differentiate between COVID-19, influenza, and respiratory syncytial virus (RSV).
Prevalent pathogens all,... Read More »
The U.S. Department of Defense awarded a $1.4 million grant to scientists at West Virginia University (WVU) to develop therapeutics to treat infections prone to antibiotic resistance.
Mariette Barbier of the WVU School of Medicine will lead the research effort. Barbier and her team will present... Read More »
The former Secretary of Health and Human Services in the Clinton administration, Donna Shalala, has been appointed to the Bipartisan Commission on Biodefense.
Shalala had been a founding member of the commission, established in 2014. She left two years ago to serve in the Congress from Florida... Read More »
Avails Medical, a Menlo Park, California diagnostics company, has secured an award worth up to $2.5 million from CARB-X to develop an electronic antibiotic susceptibility testing (AST) device.
The innovation would expedite healthcare providers’ ability to determine the most effective... Read More »
Even with the rollout of mass vaccination worldwide, COVID-19’s spread is nowhere near an immediate end.
So, it might seem perplexing when biosecurity researchers appear optimistic about a future without pandemics.
That reality is exactly what a new report has outlined. Released this week... Read More »
Combatting Antibiotic-Resistant Bacteria (CARB-X) awarded $5.3 million to Lumen Bioscience to develop a new immunotherapy to prevent diarrheal diseases caused by two specific pathogens -- Campylobacter jejuni and enterotoxigenic E. coli.
Diarrheal diseases are intestinal infections caused by... Read More »
